Zhongguancun (Daxing) Cell & Gene Therapy Industrial Park

Date: 2025-01-03

Zhongguancun (Daxing) Cell & Gene Therapy Industrial Park

Overview

Zhongguancun (Daxing) Cell & Gene Therapy Industrial Park is located in the Daxing Biomedical Base in Beijing, covering a total construction area of 130,000 square meters. The park aims to promote pioneering innovations in cell and gene therapy and novel vaccines, integrating medical care, research, education, and production into an international industrial hub.

Industry Agglomeration

The park focuses on three main areas: cell therapy, gene therapy, and novel vaccines. Currently, it houses 27 Class-I new-drug development projects, covering key directions such as cell therapy, gene therapy, and vaccine development. The park has attracted one Nobel laureate, seven academicians, and over 30 principal investigators (PIs), forming a robust talent support system.

Resources and Services

The park has built three major technology platforms for novel vaccines, cell therapy, and gene therapy, providing comprehensive service support from R&D to production. Through collaborations with universities, research institutions, and leading enterprises, the park has established an innovation consortium for the life health industry, accelerating the conversion of scientific and technological achievements. Additionally, the park offers an integrated online and offline enterprise service platform, providing a full-range sci-tech innovation service system that covers high-quality resources in innovative medical devices, cell and gene therapy, and novel vaccines, empowering the full lifecycle growth of enterprises in future health fields.